The store will not work correctly when cookies are disabled.
2-(5-methyl-3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)-5-phenyl-1,3,4-oxadiazole
ID: ALA3099513
PubChem CID: 72947072
Max Phase: Preclinical
Molecular Formula: C24H17N5O3
Molecular Weight: 423.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1c(-c2nnc(-c3ccccc3)o2)c(-c2ccc([N+](=O)[O-])cc2)nn1-c1ccccc1
Standard InChI: InChI=1S/C24H17N5O3/c1-16-21(24-26-25-23(32-24)18-8-4-2-5-9-18)22(17-12-14-20(15-13-17)29(30)31)27-28(16)19-10-6-3-7-11-19/h2-15H,1H3
Standard InChI Key: AXMNVBSMVRDHSP-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 36 0 0 0 0 0 0 0 0999 V2000
20.5780 -10.6895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7608 -10.6853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5043 -11.4613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.1630 -11.9450 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8265 -11.4679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1582 -12.7592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4468 -13.1636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4424 -13.9800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1486 -14.3930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8607 -13.9836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8616 -13.1685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6024 -11.7244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2860 -10.0238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6239 -9.2785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1476 -8.6153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3336 -8.6963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9981 -9.4461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4763 -10.1061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0612 -10.0336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8783 -10.0377 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.1348 -9.2618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4761 -8.7781 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8126 -9.2551 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9135 -9.0139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5179 -9.5655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2958 -9.3175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4704 -8.5183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8610 -7.9675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0855 -8.2184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8541 -8.0316 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0410 -8.1140 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.1892 -7.2863 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
4 6 1 0
5 12 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
2 13 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 19 2 0
1 19 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
21 24 1 0
30 31 2 0
30 32 1 0
16 30 1 0
M CHG 2 30 1 32 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 423.43 | Molecular Weight (Monoisotopic): 423.1331 | AlogP: 5.47 | #Rotatable Bonds: 5 |
Polar Surface Area: 99.88 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 1.15 | CX LogP: 5.26 | CX LogD: 5.26 |
Aromatic Rings: 5 | Heavy Atoms: 32 | QED Weighted: 0.27 | Np Likeness Score: -1.43 |
References
1. Ningaiah S, Bhadraiah UK, Doddaramappa SD, Keshavamurthy S, Javarasetty C.. (2014) Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation., 24 (1): [PMID:24316123] [10.1016/j.bmcl.2013.11.029] |